[STI571: a summary of targeted therapy]
Małgorzata Czyz1, Justyna Jakubowska
1Zakład Biologii Molekularnej Nowotworów Uniwersytetu Medycznego w Łodzi. mczyz@csk.umed.lodz.pl
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|January 25, 2007
Summary
STI571 (imatinib) is a targeted therapy for chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST). While effective, resistance can develop, necessitating new strategies to improve CML treatment outcomes.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Context:
- STI571 (imatinib) represents a pioneering molecularly targeted therapy.
- It specifically inhibits the Bcr-Abl fusion protein kinase activity, alongside c-Kit and PDGF receptors.
- Approved for chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST), it offers a low toxicity profile.
Purpose:
- To review the molecular mechanisms of STI571 (imatinib) action.
- To discuss its efficacy in treating CML, GIST, and melanoma.
- To explore strategies for overcoming STI571 resistance and enhancing treatment effectiveness.
Summary:
- STI571 (imatinib) demonstrates significant efficacy in achieving remission for CML and GIST patients.
- However, primary and secondary resistance to STI571 poses a challenge, limiting its ability to eradicate all BCR-ABL-positive stem cells.
- Novel therapeutic approaches are being developed to enhance STI571 effectiveness, focusing on overcoming resistance mechanisms.
Impact:
- STI571 (imatinib) has revolutionized CML and GIST treatment by introducing targeted therapy.
- Understanding resistance mechanisms is crucial for developing next-generation therapies.
- Future strategies aim to improve long-term remission rates and patient outcomes by addressing drug resistance.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...